Supplier profile
THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER
Every public-sector award we hold for this supplier, across the United States, from 10 Aug 2009 to 6 Aug 2026.
Awards won
62
all time
Attributed value
$139.7m
as published
Buyers
6
public bodies
Active
2009–2026
first to latest award
Awards by year
Who they win from
| Buyer | Awards | Value |
|---|---|---|
| National Institutes of Health | 41 | $45.2m |
| Food and Drug Administration | 11 | $3.9m |
| Department of Veterans Affairs | 4 | $2.1m |
| Department of the Navy | 3 | $3k |
| Health Resources and Services Administration | 2 | $88.3m |
| Centers for Disease Control and Prevention | 1 | $151k |
What they win
Awards
Showing 51–62 of 62 awards we hold
- Prevention Of Hepatocellular Carcinoma (Hcc) Associated With Non-Alcoholic Steatohepatitis (Nash) ↗National Institutes of Health£729kawarded 20 Jul 2018
- Igf::ot::igf Pilot Study Of Denosumab In Brca1/2 Mutation Carriers Scheduled For Risk-Reducing Salpingo-Oopherectomy ↗National Institutes of Health£263kawarded 19 Sept 2017
- Igf::ot::igf Targeting The Mtor Pathway For The Prevention Of Breast Cancer ↗National Institutes of Health£714kawarded 15 Sept 2017
- Igf::ot::igf A Phase I Dose Escalation Study Of Topical Bexarotene In Women At High Risk For Breast Cancer ↗National Institutes of Health£556kawarded 7 Sept 2017
- Igf::ot::igf Determination Of Dosing Regimens Of Erlotinib In Combination With Sulindac For Prevention Of Colorectal Cancer While Reducing Agent Toxicity Pop 06/01/2017 - 05/31/2019 ↗National Institutes of Health£979kawarded 16 May 2017
- Igf::ot::igf A Randomized, Double-Blind, Placebo-Controlled Study Of 4-Hydroxytamoxifen Topical Gel In Women With Mammographically Dense Breasts ↗National Institutes of Health£2.2mawarded 16 Sept 2016
- Igf::ot::igf Core Infrastructure Support ↗National Institutes of Health£4.2mawarded 16 Sept 2015
- Igf::ot::igf Vadis Trial: Phase Ii Trial Of E75 Peptide Vaccine In Women With Dcis Of The Breast ↗National Institutes of Health£502kawarded 15 Sept 2015
- Igf::ot::igf Alternative Dosing Of Exemestane In Postmenopausal Women With Stage 0-Ii Er-Positive Breast Cancer: A Randomized Presurgical Trial ↗National Institutes of Health£1.6mawarded 31 Jul 2015
- Squirrel Monkeys, Bolivia, Either Gender, Greater Than 700 Gram, Established Pairs Preferred, Spf (Ref. N1) ↗National Institutes of Healthawarded 16 Jan 2015
- Tas::75 0350::tas - Provide For The Collection And Maintenance Of Genetically Diverse, High-Quality Umbilical Cord Blood Units For Inclusion In The National Cord Bllod Inventory ↗Health Resources and Services Administration£30.4mawarded 8 Sept 2010
- Biomedical (Basic) ↗National Institutes of Health£4.9mawarded 10 Aug 2009
Bidding against them?
Get new tenders in their space in a daily digest, scored against your own capability — plus the full notice behind each of these awards, with the documents and contacts it published.
Start 7-day free trialHow this profile is built
Awards are collected from official public procurement notices and deduplicated so one procurement counts once. Supplier names are grouped across their published spellings: case and punctuation are ignored, and “Ltd” is treated as optional because buyers routinely leave it off. Everything else that marks a different organisation is kept — an LLP, a plc, a CIC and a Teoranta are separate businesses from a Ltd of the same name, as are a parent and a named subsidiary, and none of them are merged here. Where another entry differs from this one only by legal form or a bracketed qualifier it is listed above as possibly the same organisation — a hint for the reader, never a merge: figures are per legal entity and never combined. Value is attributed only where the notice is explicit: the supplier's own itemised amount, or the whole value where they were the sole named supplier. Awards naming several suppliers without a published split are counted and marked shared, never valued, and a framework ceiling is never treated as money any one appointed supplier won. Sterling and euro are never added together. The linked source notice is authoritative.
Company pages are for organisations. If this page profiles you as an individual — a sole trader or an individual contractor — you can ask for it to be withheld: see how.